ETFChannel.com
SLIDESHOW: The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks
| This Slide: #1 of 15 |
#15 of the Dow 30: Pfizer Inc (NYSE:PFE)
Pfizer is a research-based biopharmaceutical company. Co.'s portfolio includes medicines and vaccines, as well as consumer healthcare products. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Co.'s health business units (except Consumer Healthcare) as well as a hospital business unit that commercializes its portfolio of sterile injectable and anti-infective medicines; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Viagra and Celebrex, as well as certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business. 
Open the PFE Page at ETF Channel »
|
|||||||||||||||||||||
Open the ETF Channel PFE Page (in a new window) »
PFE Average Broker Rec.
 
|
Buy (3.15 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
| Avg. Broker Rec.
|
Buy (3.15 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Analysts Forecast: PFE Price Target Based on data provided by Zacks Investment Research via Quandl.com |
|
|
